Merck Says Its Covid Pill Is Less Effective in a Final Analysis

Merck says its antiviral pill is less effective in a final analysis.

Taking New Aim at COVID-19: Treatments Against the Coronavirus’s Tangled Strands of RNA

WHO Names New Covid-19 Coronavirus Variant Of Concern ‘Omicron’